References
- Mutlu C, Odabasi AO, Metin K, Basak S, Erpek G. Sensorineural hearing loss associated with otitis media with effusion in children. Int J Pediatr Otorhinolaryngol 1998;46:179–84.
- Ryding M, Konradsson K, White P, Kalm O. Hearing loss after “refractory” secretory otitis media. Acta Otolaryngol 2005;125:250–5.
- Paparella MM, Morizono T, Le CT. Sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol 1984;93:623–9.
- Papp Z, Rezes S, Jókay I, Sziklai I. Sensorineural hearing loss in chronic otitis media. Otol Neurotol 2003;24:141–4.
- Aviel A, Ostfeld E. Acquired irreversible sensorineural hearing loss associated with otitis media with effusion. Am J Otolaryngol 1982;3:217–22.
- Yellon RF, Rose E, Kenna MA, Doyle WJ, Casselbrant M, Diven WF, Sensorineural hearing loss from quinolinic acid: a neurotoxin in middle ear effusion. Laryngoscope 1994;104:176–81.
- Hanson JB, Russell PT, Chung AT, Kaura CS, Kaura SH, John EO, Effect of round window membrane application of nitric oxide on hearing and nitric oxide concentration in perilymph. Int J Pediatr Otorhinolaryngol 2003;67:585–90.
- Santamaría D, Espinoza-González V, Ríos C, Santamaría A. Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem Res 1999;24:843–8.
- Takahashi M, Niwa H, Yanagita N. PO2 levels in middle ear effusions and middle ear mucosa. Acta Otolaryngol Suppl 1990;471:39–42.
- Yamashita T, Saka H, Okazaki N, Kumazawa T. A cause of sensorineural hearing loss in otitis media with effusion. Auris Nasus Larynx 1985;12(Suppl I):S40–2.
- Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. Transactivation and inhibitory domains of hypoxia inducible factor 1 alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997;272:19253–60.
- Patterson JI, Brown RR. Determination of urinary quinolinic acid by high-performance liquid chromatography. J Chromatogr 1980;182:425–9.
- Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res 2001;49:614–17.
- Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1a and insulinlike factor 2. Cancer Res 1999;59:3915–18.
- Sumbayev VV, Nicholas SA. Hypoxia-inducible factor 1 as one of the “signaling drivers” of toll-like receptor-dependent and allergic inflammation. Arch Immunol Ther Exp (Warsz) 2010;58:287–94.
- Rose AS, Prazma J, Randell SH, Baggett HC, Lane AP, Pillsbury HC. Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg 1997;116:308–16.
- Capper R, Guo L, Pearson JP, Birchall JP. Effect of nitric oxide donation on mucin production in vitro. Clin Otolaryngol Allied Sci 2003;28:51–4.
- Carhart R. The clinical application of bone conduction audiometry. Arch Otolaryngol 1950;51:798–808.
- Gatehouse S, Browning GG. A re-examination of the Carhart Effect. Br J Audiol 1982;16:215–20.
- Ahmad I, Pahor AL. Carhart's notch: a finding in otitis media with effusion. Int J Pediatr 2002;64:165–70.